Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)

NCT01767909 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01767909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01767909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effects of Intranasally-Administered Insulin in Adults With Amnestic Mild Cognitive Impairment (aMCI) or Mild Alzheimer's Disease (AD)
Lead sponsor
University of Southern California
Phase
Phase 2/3
Overall status
Completed
Start date
January 8, 2014
Completion date
December 11, 2018
Enrollment
240 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, amnestic mild cognitive impairment